 Check-Cap Ltd. the Company or Check-Cap NASDAQ: CHEK NASDAQ: CHEKW, NASDAQ: CHEKZ, a clinical stage medical diagnostics company advancing the development of the C-Scan System, the first and only preparation-free ingestible scanning capsule based system for the prevention of colorectal cancer through the detection of precancerous polyps, today announced that the Company has entered into definitive agreements with certain investors to purchase approximately 4.75 million of its ordinary shares in a private placement. 